Arctic Bioscience ASOSL:ABS -1.85%56 Days Inventory is 322.90 as of Dec. 2025, which is 27% below its 10-year median of 442.15. GuruFocus rates OSL:ABS with a GF Score™ of 56/100 and a GF Value™ of kr10.62 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 637 Biotechnology companies, Arctic Bioscience AS ranks worse than 76.45% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Arctic Bioscience AS's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.57.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arctic Bioscience AS's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.36.
Arctic Bioscience AS (OSL:ABS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Arctic Bioscience AS's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arctic Bioscience AS's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Arctic Bioscience AS Days Inventory Related Terms
Arctic Bioscience AS Days Inventory Historical Data
* Premium members only.
The historical data trend for Arctic Bioscience AS's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:ABS vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Arctic Bioscience AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arctic Bioscience AS Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's Days Inventory distribution charts can be found below:
* The bar in red indicates where Arctic Bioscience AS's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arctic Bioscience AS (OSL:ABS) has a Days Inventory of 322.90 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arctic Bioscience AS and its competitors. This is 27% below median its historical median of 442.15. Over the past decade, Arctic Bioscience AS's Days Inventory has ranged from 342.39 to 611.15. According to the industry distribution chart, Arctic Bioscience AS ranks #487 out of 637 companies in the Biotechnology industry, placing it in the top 76.5%.
Is Arctic Bioscience AS's Days Inventory too high?
Arctic Bioscience AS's current Days Inventory of 322.90 is 27% below median its 10-year median of 442.15. Over the past 10 years, this metric has ranged from a low of 342.39 to a high of 611.15. The Biotechnology industry median Days Inventory is 183.23. Arctic Bioscience AS's value of 322.90 is 76.2% above this industry median. Based on the distribution chart, Arctic Bioscience AS ranks #487 out of 637 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Arctic Bioscience AS has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arctic Bioscience AS ranks #487 out of 637 companies for Days Inventory. This places Arctic Bioscience AS in the lower half of its industry. The industry median Days Inventory is 183.23. Arctic Bioscience AS's value of 322.90 is 76.2% above this benchmark. Historically, Arctic Bioscience AS's own Days Inventory has ranged from 342.39 to 611.15 over the past decade. While the company's 10-year median is 442.15 vs. the industry median of 183.23, Arctic Bioscience AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arctic Bioscience AS's current Days Inventory of 322.90 is 76.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arctic Bioscience AS and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arctic Bioscience AS's current Days Inventory is 322.90, which is 27% below median its own 10-year median of 442.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (OSL:ABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.62, compared to a current price of kr3.19 — trading 70% below its estimated fair value. The current Days Inventory is 322.90, which is 27% below median its 10-year median of 442.15 and 76.2% above the Biotechnology industry median of 183.23. Arctic Bioscience AS's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Arctic Bioscience AS (OSL:ABS), the current Days Inventory is 322.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?
Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued.
The current stock price of kr3.19 is trading 70% below its estimated GF Value™ of kr10.62.
GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.
Key valuation signals for OSL:ABS:
Days Inventory: 322.90 (27% below median its 10-year median of 442.15)
GF Value™: kr10.62 vs. price of kr3.19 (70% below fair value)
Industry Position: 76.2% above the Biotechnology median (#487 of 637)
No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
56GF Score
Get the complete analysis for OSL:ABS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:ABS has been successfully added to your 
